Larsson A, Pisarri-Salsano S, Ohlander C, Natvig J B, Perlmann P
Scand J Immunol. 1975;4(3):241-52. doi: 10.1111/j.1365-3083.1975.tb02623.x.
A human anti-dextran serum, EAK, with IgG antibodies restricted to subclass IgG2, was tested for its capacity to induce lysis of dextran-coated chicken erythrocytes by normal human lymphocytes or monocytes. Another human anti-dextran serum, RGM, with most antibodies belonging to sublass IgG1, and a hyperimmune rabbit anti-dextran serum were used for reference. In lymphocyte-mediated erythrolysis, serum EAK gave rise to 51-Cr release varying from 20% to 80% in different experiments. The hyperimmune rabbit serum was 100 to 1000 times more active, whereas serum RGM was consistently negative. These results correlated well with the concentration of anti-dextran antibodies in these sera. In monocyte-mediated erythrolysis serum EAK had a somewhat higher titer than in lymphocyte-mediated lysis, and serum RGM had a weak but significant activity at low dilutions. Serum EAK also induced erythrophagocytosis by monocytes. Ultracentrifugation did not significantly decrease the inductive capacity of this serum. The results show that antibodies of human sublass IgG2 are efficient inducers of effector functions in both lymphocytic and monocytic cells. Myeloma proteins of the four IgG subclasses were tested for inhibitory capacity in lymphocyte- or monocyte-mediated erythrolysis. Either serum EAK or the rabbit reference serum was used for induction of erythrolysis. Individual myeloma proteins within and between the subclasses varied considerably in inhibitory power. However, whereas IgG1, IgG2, and IgG3 proteins inhibited lymphocyte-mediated erythrolysis induced by either type of antiserum, the two IgG4 proteins tested were essentially negative. These results suggest a lack of specificity of the Fc receptor for subclasses IgG1, IgG2, and IgG3 in both heterologous and homologous inhibition. In monocyte-mediated erythrolysis, IgG1 and IgG3 were strong inhibitors, whereas inhibition by IgG2 and IgG4 was weak and inconsistent. This pattern was seen regardless of whether and inducing antiserum was of rabbit or human origin. Similar results were obtained in monocyte-induced erythrophagocytosis induced by serum EAK. These and previous results suggest that effector cells of the lymphocytic (K cell) variety have Fc receptors different from those of monocytic cells. However, the basis for the differences observed in the inhibition tests remains to be elucidated.
对一种人抗右旋糖酐血清EAK进行了检测,其IgG抗体局限于IgG2亚类,检测内容为该血清诱导正常人淋巴细胞或单核细胞对右旋糖酐包被的鸡红细胞进行裂解的能力。另外两种抗右旋糖酐血清用作对照,一种是大多数抗体属于IgG1亚类的人抗右旋糖酐血清RGM,另一种是超免疫兔抗右旋糖酐血清。在淋巴细胞介导的红细胞溶解中,血清EAK在不同实验中引起的51-Cr释放率在20%至80%之间。超免疫兔血清的活性高100至1000倍,而血清RGM始终呈阴性。这些结果与这些血清中抗右旋糖酐抗体的浓度密切相关。在单核细胞介导的红细胞溶解中,血清EAK的效价比在淋巴细胞介导的溶解中略高,血清RGM在低稀释度时有微弱但显著的活性。血清EAK还诱导单核细胞进行红细胞吞噬作用。超速离心并没有显著降低该血清的诱导能力。结果表明,人IgG2亚类抗体在淋巴细胞和单核细胞中都是效应功能的有效诱导剂。对四种IgG亚类的骨髓瘤蛋白进行了淋巴细胞或单核细胞介导的红细胞溶解抑制能力测试。血清EAK或兔对照血清用于诱导红细胞溶解。亚类内和亚类间的个别骨髓瘤蛋白的抑制能力差异很大。然而,IgG1、IgG2和IgG3蛋白能抑制由两种抗血清诱导的淋巴细胞介导的红细胞溶解,而所检测的两种IgG4蛋白基本呈阴性。这些结果表明,在异源和同源抑制中,Fc受体对IgG1、IgG2和IgG3亚类缺乏特异性。在单核细胞介导的红细胞溶解中,IgG1和IgG3是强抑制剂,而IgG2和IgG4的抑制作用较弱且不稳定。无论诱导抗血清是兔源还是人源,均出现这种模式。在血清EAK诱导的单核细胞介导的红细胞吞噬作用中也获得了类似结果。这些结果以及之前的结果表明,淋巴细胞(K细胞)类型的效应细胞具有与单核细胞不同的Fc受体。然而,抑制试验中观察到的差异的基础仍有待阐明。